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SUMMARY ∑ With the introduction of breath-hold techniques, magnetic resonance (MR) imag-
ing has become an excellent diagnostic tool for the detection and characterization of benign and
malignant liver lesions. Dynamic, gadolinium postcontrast studies as well tissue-specific contrast media
highly improve the characterization of liver lesions. Multisection breath-hold techniques enable
imaging of the entire region of interest in a single suspended respiration. MR-cholangiopan-
creatography allows for simultaneous analysis of biliary tree and pancreatic duct. The ability of vari-
ous MR pulse sequences to display differences between normal and pathologic tissues is the basis of
detection and characterization of focal and diffuse liver changes.
Cyst
Ultrasound (US), computed tomography (CT) and
magnetic resonance imaging (MRI) have similar possibili-
ties in detection and evaluation of cystic lesions. On MRI,
simple cysts are shown as round or oval, sharply defined ho-
mogeneous lesions with very low signal intensity on T1
weighted images and homogeneous very high signal inten-
sity on T2 weighted images1. On postcontrast scans, they
resemble void signal intensity (Fig. 1). Hemorrhagic cysts
show an increase of signal intensity according to time of
bleeding2. Septa and daughter cysts in case of echinoccocus
are well visualized as linear structures within the cyst (Figs.
2a, b). TRUFI and HASTE breath-hold sequences show
cysts as high signal intensity lesions (Fig. 2c). Occasionally
abscesses have similar morphology as cysts (Fig. 3).
Hemangioma
Differentiation of hemangiomas from other focal liver
lesions is of great importance, as they occur in 1% to 20%
of the population3,4. The majority of hemangiomas are
asymptomatic measuring from few millimeters to 20 cen-
timeters, and require no treatment. Sometimes (15%) they
produce the symptoms of nausea, abdominal pain and
vomiting due to rupture, hemorrhage or extrinsic com-
pression of adjacent structures. Hemangiomas have a fe-
male/male ratio of 5:1, and are multiple in 50% of patients.
The usual US description of hemangioma is that of a well
defined, rounded, echogenic homogeneous lesion, usually
less than 2 centimeters in size. Sometimes, hemangiomas
on US show a hypoechoic inhomogeneous pattern, mak-
ing impossible differentiation from other necrotic liver
tumors5,6.
Hemangiomas are hypodense on native CT scans,
whereas on dynamic postcontrast scans they exhibit
marked edge enhancement.
On MRI, hemangiomas appear as low-signal inten-
sity lesions on T1 weighted images (Fig. 4a, 4b), whereas
on T2 weighted images they display a high-intensity ap-
pearance7,8 (Fig. 4c) . The areas of low-signal intensity
correspond with fibrous tissue. MRI is very sensitive in
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Fig. 1. Polycystic disease. Postcontrast breath-hold in phase sequence
with multiple liver and kidney cysts without enhancement after
administration of GD-DTPA. Fig. 2a Echinococcus cyst. Breath-hold out of phase sequence show-
ing a low to medium signal intensity cyst.
Fig. 2b. Postcontrast breath-hold out of phase sequence showing dis-
crete linera septa within unenhanced echinococcus cyst.
Fig. 2c. On HASTE sequence, the cyst is of a high signal intensity.
detection and differentiation of hemangiomas from other
focal liver lesions, whereas on T2 weighted images with
very long TR they hold high-intensity appearance, oppo-
site to other solid and cystic lesions. Breath-hold tech-
niques enable dynamic postcontrast studies which dem-
onstrate hemangiomas as edge nodular enhancing lesions
in the arterial phase with central hypointensity, due to
large peripheral feeding vessels9,10 (Fig. 4d). Small he-
mangiomas (less than 2 cm) demonstrate uniform en-
hancement and on delayed scans they become isointense
with liver parenchyma. Some large hemangiomas have a
central stellate area similar to the central scar of focal
nodular hyperplasia (FNH), and exhibit nodular enhance-
ment progressing centripetally. The scar in hemangioma
has low signal intensity on T2 weighted images due to
fibrous tissue11. The central scar of FNH consists of rich
M. Marotti et al. 3rd Congress of Croatian Society of Radiology with International Participation
Acta clin Croat, Vol. 41, No. 1, 2002 43
Focal Nodular Hyperplasia and
Hepatocellular Adenoma
According to one report, CT is less sensitive in detec-
tion of FNH than US7. Hepatic adenomas cannot be dif-
ferentiated on the US basis from FNH. MRI has been
reported to be able to detect the central scar not detect-
Fig. 3 Breath-hold out of phase oblique postcontrast sequence. Post-
cholecystectomy abscess in the gallbladder fossa.
Fig. 4a Breath-hold in phase coronal sequence showing a heman-
gioma of low signal intensity.
Fig. 4b. Postcontrast breath-hold in phase coronal sequence showing
homogeneous diffuse enhancement of the lesion.
Fig. 4c. Postcontrast breath-hold in phase coronal sequence showing
edge enhancement of the lesion.
vascular fibrous tissue and exhibits high signal intensity
on T2 weighted images12-14. Metastases from endocrine
tumors may have extremely high signal intensity and can
be misdiagnosed as hemangiomas. Confirmation of he-
mangioma is possible after administration of SPIO par-
ticles with strong increase of signal intensity on post-
contrast T1 weighted images15.
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able by US or CT, and can differentiate FNH from me-
tastasis13,14,16,17. FNH appears on MRI as an isointense
or slightly hypointense lesion on T1 weighted images (Fig.
5a). On T2 weighted images, FNH is isointense with liver
parenchyma with a scar of high signal intensity (Fig. 5b).
The central scar appears hypointense on T1 weighted
images and hyperintense on T2 weighted images due to
fresh connective tissue with rich vascularity.
In the early phase, FNH shows strong enhancement
of the parenchymal part of the lesion compared to nor-
mal liver parenchyma, while the central scar remains
unenhanced18-21 (Fig. 5c). In the delayed phase, the pa-
renchymal part of the lesion becomes isointense with the
liver, while the central scar shows increase in signal inten-
sity. This biphasic enhancement pattern is specific for
FNH. On T2 weighted images, the parenchymal part of
the lesion is isointense with the liver, while the central scar
exhibits high signal intensity. Hepatocellular adenoma
may have slightly hypointense (Fig. 6a) or increased sig-
nal intensity on T1 weighted images due to the high gly-
cogen content. Hemorrhage within adenoma shows high
signal intensity on T1 as well as on T2 weighted images.
The hypervascular nature of hepatocellular adenoma
shows early enhancement after administration of contrast
Fig. 5a Breath-hold out of phase coronal image of focal nodular hy-
perplasia. The lesion is mostly of extrahepatic location with a cen-
tral scar.
Fig. 4d Breath-hold T2 weighted image showing homogeneous high
signal intensity of hemangioma.
Fig. 5b. Breath-hold T2 weighted image. Focal nodular hyperpla-
sia is isointense with liver parenchyma.
Fig. 5c. Breath-hold in phase postcontrast image of focal nodular
hyperplasia with a central scar.
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media with rapid washout (Fig. 6b). Delayed postcontrast
image demonstrates isointensity of the lesion with liver
parenchyma (Fig. 6c).
Hepatocellular Carcinoma
US and CT are equally accurate in the detection of
hepatocellular carcinoma22-24. Ultrasound appearance of
hepatocellular carcinoma is variable. Small lesions are
usually hypoechoic. Larger lesions have increased
echogenicity. Intraluminal vessel tumor invasion is readily
recognized by US. Diffuse form of hepatocellular carci-
noma is very difficult to demonstrate with CT despite the
application of contrast media.
MRI usually differentiates hepatocellular carcinomas
from other liver lesions due to the presence of tumor cap-
sule, intratumoral septa, daughter nodules, central scar-
ring and tumor thrombi in portal or hepatic veins25-29.
Hepatocellular carcinoma is predominantly supplied by
the hepatic artery, which results in early arterial contrast
enhancement. On T1 weighted images, hepatocellular
carcinoma shows various signal intensities, from hypo-to
iso- or hyperintense values31-35 (Fig. 7a). On T2 weighted
images, most of them (80%) show high signal intensity
compared with liver parenchyma (Fig. 7b). Well differen-
tiated tumors exhibit high signal intensity on T1 weighted
images and isointensity on T2 weighted images. Poorly
differentiated hepatocellular carcinoma demonstrates low
signal intensity on T1 weighted images and hyperintensity
on T2 weighted images36. Poorly differentiated tumors
demonstrate infiltrative characteristics, whereas well dif-
ferentiated tumors show only expansive pattern. Enhance-
ment of hepatocellular carcinoma on postcontrast images
depends on the degree of differentiation37,38. Generally,
there is a peak of enhancement in the early arterial phase,
whereas some of well differentiated tumors show the lack
of peak enhancement during the early arterial phase (Fig.
7c). Detection of tumor capsule with MRI is important
for differential diagnosis, as it has been seldom found in
metastases or cholangiocarcinoma and very often in hepa-
Fig. 6a Breath-hold in phase sequence showing hypointense lesion
of hepatic adenoma.
Fig. 6b. Breath-hold in phase postcontrast arterial phase image
showing a early high signal intensity enhancement of the adenoma.
Fig. 6c. Breath-hold in phase delayed postcontrast image shows
isointensity of the lesion with liver parenchyma.
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tocellular carcinoma. The capsule has low-signal intensity
on T1 weighted images (Fig. 7c). Intravascular spread of
hepatocellular carcinoma is an important staging and
prognostic sign. MRI is capable of differentiating tumor
thrombus from other thrombotic masses by demonstrat-
ing the increase of signal intensity of the thrombus on
arterial postcontrast scans. Enhancement is identical to
enhancement of the main tumor39-41. Detection and dif-
ferentiation of hepatocellular carcinoma from other liver
tumors is improved with hepatobiliary contrast media42.
MRI breath-hold sequences have shown similar sensitivity
and specificity as spiral CT in the detection and charac-
terization of hepatocellular carcinoma as well as in differ-
entiation from macroregenerative nodules42,43. Meticulous
search for liver metastases is needed because they are fre-
quently associated with hepatocellular carcinoma and their
finding is of major importance for therapy planning.
Fig. 7a Breath-hold in phase sagittal image showing a well demar-
cated hypointense hepatocellular carcinoma.
Fig. 7b Breath-hold in phase postcontrast arterial phase image show-
ing inhomogeneous enhancement of hepatocellular carcinoma with
a low intensity capsule.
Fig. 7c Breath-hold HASTE sequence showing an inhomogeneous
lesion of high signal intensity.
Fig. 8. Breath-hold out of phase postcontrast image with rim en-
hancement of cholangiocarcinoma and dilated bile ducts.
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Cholangiocellular Carcinoma
Cholangiocarcinoma or peripheral cholangiocarcinoma
is the second most common primary liver neoplasm after
hepatocellular carcinoma. On T1 weighted images cholan-
giocarcinoma is mostly hypointense, and on T2 weighted
images it may be of isotense or hyperintense signal intensity.
On T2 weighted images, a central scar due to fibrous tissue
is often present. The lesion has lobulated margins and ab-
sence of capsule. On postcontrast scans with GD-DTPA,
there is slight rim enhancement (Fig. 8), less than in heman-
giomas, with moderate progresive fill-in44. Dilatation of the
peripheral bile ducts is seen in 20%-68% of cases (Fig. 8).
Metastases
Patients with liver metastases who undergo surgical
resection of the secondary deposits have improved long-
term survival rates compared to similar patients who do not
undergo resection45-47. Preoperative diagnostic imaging
evaluation of metastases should be performed to detect the
number, size, segmental location and relationship to hepatic
vasculature. Recent advances in CT, US and MRI have
improved detection of liver neoplasms. CT is the estab-
lished method for detection and evaluation of secondary
liver deposits23-25,48. According to recent studies, MRI has
become an important diagnostic technique for detection of
focal liver lesions49-53. Liver tumor nodules are detected at
small size and in most cases the lesions can be character-
ized with high reliabillity54-60. In spite of the newer imag-
ing methods available, US is a sensitive and accurate mo-
dality for the identification, localization and characteriza-
tion of focal hepatic abnormalities61-64. Because of the ab-
sence of irradiation exposure, easy use and low cost, US
plays a major role in hepatic imaging.
Patients with malignant disease considered for hepatic
resection should have accurate preoperative imaging evalu-
ation, because the number and distribution of lesions de-
Fig. 9a Breath-hold in phase sequence with low signal intensity liver
metastases of colon carcinoma.
Fig. 9b Breath-hold in phase postcontrast image with rim enhance-
ment of the lesions.
Fig. 9c Breath-hold in phase postcontrast image with rim enhance-
ment of a 6mm metastatic lesion.
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termines therapeutic approach. Clinical studies have shown
improved survival rates after resection of primary and me-
tastasis lesions65-66. There is only a few studies dealing with
the sensitivity and specificity of low-field MRI compared
with CT41.
On breath-hold T1 weighted sequences, metastases
demonstrate low signal intensity with rim enhancement
on postcontrast studies (Fig. 9a, b, c). Metastases show
signal hyperintensity compared to liver parenchyma on T2
weighted images on MRI. Most metastases have regular
borders and homogeneous signal intensity, as shown by
Brown et al. One study demonstrated the ability and ad-
vantages of detection of liver metastasis disease with low-
field MR imaging versus contrast enhanced CT43. The
result is comparable to conclusions of three comparative
studies, stating that an intermediate field strength MR
imaging is superior to contrast enhanced CT in the de-
tection of hepatic metastases67-68. In contrast, some au-
thors claim that contrast enhanced CT is superior in the
detection of hepatic metastases because of better resolu-
tion and lower susceptibility to artifacts69.
The study performed on low-field magnet has shown
that T1 weighted sequence detected 51% and CT 63%
of the liver lesions demonstrated by T2 weighted se-
quence47. T2 weighted images on spin-echo sequence
have shown identical sensitivity in the detection of liver
metastases as inversion recovery technique. CT demon-
strated 92% of the lesions detected by inversion recov-
ery technique.
Diffuse Liver Disease
Hepatomegaly is present when a length of 15.5 cm is
found in the midclavicular line69. Values under 13 cm are
within the normal range. Values between 13 and 15.5 cm
are indeterminate70.
Fatty infiltration of the liver is present in various patho-
logic conditions such as obesity, alcohol abuse, cirrhosis,
diabetes mellitus, trauma, toxic substances, metabolic dis-
ease and others71. Fatty infiltration of the liver produces
increased ultrasonic echogencity. CT is a method which
accurately detects fatty liver infiltration with liver densities
under 40 Hounsfield units. Spin-echo MRI using usual
imaging techniques is not capable to detect fatty liver72.
With the introduction of breath-hold in phase and out-of-
phase sequences MRI is capable of demonstrating fatty liver
deposit. There is a loss of signal on the out-of-phase se-
quence compared to in-phase sequence (Fig. 10a, b).
Hemochromatosis is readily demonstrated by CT and
MRI. On CT, hemochromatosis appears as a diffuse in-
crease in densities up to 95 Hounsfield units. MR spin-
echo T1 weighted image shows extremely low signal in-
tensity of liver parenchyma in hemochromatosis (Fig. 11).
Liver Cirrhosis
US, CT and MRI have no single specific echosono-
graphic, CT density or MRI signal alteration in liver cir-
Fig. 10a Breath-hold in phase sequence showing uniform normal
signal intensity of the liver.
Fig. 10b Breath-thold out of phase image showing an area of lower
signal intensity due to fatty liver deposit.
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rhosis. US echogencity, CT densities and MR signal in-
tensities are mostly heterogeneous. The diagnosis is
achieved according to specific morphologic liver changes
and ascites (Fig. 12).
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